The Ohio State University (OSU) SCREEN Community Program

Conditions studied

Breast Carcinoma, Cervical Carcinoma, Colorectal Carcinoma

About this study

This clinical trial develops and tests how well a multi-level intervention (MLI), The Ohio State University (OSU) SCREEN Community Program, works to increase screening and follow-up for breast, cervical and colorectal (CRC) cancer among low-income and un/underinsured female residents in three counties in Central Ohio. In Ohio, incidence and mortality rates for breast, cervical and CRC are higher than or similar to the national average; in addition, underserved populations - minority, rural and low-income women - have higher rates of these cancers. Screening can detect precancerous colorectal and cervical lesions and other early-stage cancers when treatment is less intensive and more successful and is known to reduce mortality rates for breast, cervical, and CRC, however many of these women lack access to health care and screenings. This MLI includes clinic-based components, such as patient education, as well as community-based strategies, such as media programs and training health workers, that can increase rates of guideline-recommended breast, cervical and CRC screening and follow-ups in underserved populations. The OSU SCREEN Community Program may be an effective way to improve breast, cervical and CRC screenings among underserved women in Ohio.

Interventions

• Other: Cancer Screening — Undergo cancer screening
• Other: Discussion — Participate in discussions
• Other: Educational Activity — Receive coaching calls
• Other: Educational Intervention — Receive educational materials
• Behavioral: Focus Group — Participate in focus group
• Other: Health Care Delivery — Integrate new activities into usual clinic processes
• Other: Health Promotion — Promote screening and wellness visits
• Other: Health Promotion and Education — Participate in educational sessions
• Other: Health Promotion and Education — Participate in early wave MLI
• Other: Health Promotion and Education — Participate in late wave MLI
• Behavioral: Health Risk Assessment — Incorporate risk assessments
• Procedure: Implementation — Implement MLI

Primary outcomes

• Up to date (UTD) status for all three screenings (Early Intervention Wave) (At baseline and at the end of the Implementation Phase (up to 4 years))
• Status of follow-up for abnormal tests (Early Intervention Wave) (At baseline and at the end of the Implementation Phase (up to 4 years))

Eligibility information

Study locations

• Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States